Hyperprogressive Disease: Main Features and Key Controversies

Arasanz, H; Zuazo, M; Bocanegra, A; Chocarro, L; Blanco, E; Martinez, M; Morilla, I; Fernandez, G; Teijeira, L; Morente, P; Echaide, M; Castro, N; Fernandez, L; Garnica, M; Ramos, P; Escors, D; Kochan, G; Vera, R

Arasanz, H; Escors, D (corresponding author), Univ Navarra, Fdn Miguel Servet Publ, IdiSNA, Oncoimmunol Grp,Navarrabiomed, Pamplona 31008, Spain.; Arasanz, H; Vera, R (corresponding author), Complejo Hosp Navarra IdiSNA, Dept Med Oncol, Pamplona 31008, Spain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021; 22 (7):

Abstract

Along with the positioning of immunotherapy as a preferential treatment for a wide variety of neoplasms, a new pattern of response consisting in a sud......

Full Text Link